SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Human Genome Sciences, Inc. (HGSI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Joseph wang who wrote (7)7/25/1996 9:44:00 PM
From: Knighty Tin   of 1127
 
Joseph, I am a big HGSI fan and loved the eps, but if the consensus estimate was a negative 53 cents, then the analysts were out to lunch. I really didn't expect 13 cents, more like breakeven, but had they made minus 53 cents I would have been unpleasantly surprised. Anyway, they have more revenues coming in from partners and those partners are progressing on research that could add huge profits if they get any decent selling drugs. Given how many companies are working on different products, I think it is a sure thing. The only question is whether the first big drug comes to market in two years or in 5 years. Good luck, MB
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News